Using NGS to detect mutations, and then ddPCR for further analysis, mutations in ERBB2 (either in exon 17 or 27) have been detected in the ctDNA of 20% of pancreatic cancer patients. Here, ERBB2 is linked to familial pancreatic carcinoma.